Both the public and private sectors contribute significantly to cancer research funding. Government agencies provide large-scale, stable funding for fundamental and translational research. In contrast, private sector funding from pharmaceutical companies often focuses on the development of new drugs and therapies. Non-profit organizations and foundations fill gaps by supporting innovative, early-stage research and providing funding for underserved areas.
